On Jan. 15, 2025, a warning letter was sent to Sanofi stating that FDA inspectors found irregularities with the facility's bioreactor, the vessel used to grow organisms and cells. According to the ...
THURSDAY, Jan. 23, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from Current Good Manufacturing Practice ...
Stocks like CIE Automotive India, Sanofi Consumer Healthcare, Delta Corp, Mahindra and Mahindra, Grindwell Norton, Keystone ...
On Jan. 15, 2025, a warning letter was sent to Sanofi stating that FDA inspectors found irregularities with the facility’s bioreactor, the vessel used to grow organisms and cells. According to the ...
HRSA said that drug rebates are illegal under the 340B ... On Dec. 13, HRSA sent Sanofi a warning letter, urging the drugmaker to halt its rebate model. Sanofi has paused implementation and ...
This warning chimes with comments ... Among the signatories of the open letter are Novartis’s research supremo Jay Bradner, Elias Zerhouni’s R&D chief at Sanofi, Patrick Vallance, president ...